Ting Yuan: Rethinking Oocyte Quality Through Reproducible Patterns
Ting Yuan, Co-Founder and Clinical Director at Zhaoxi Fertility Center Malaysia, shared a post on LinkedIn:
“A recent case made me pause.
A 41-year-old patient underwent multiple IVF cycles across different centres, yet showed a remarkably consistent pattern: reasonable oocyte yield, fertilisation achieved, but repeated embryo arrest before blastocyst, with occasional aneuploid blastocysts.
When outcomes are this consistent across centres, it raises an important question: how much of what we attribute to ‘lab variability’ may actually be intrinsic to the oocyte?
In practice, ‘oocyte quality’ is often used as a broad category.
But cases like this suggest there may be different underlying patterns – some potentially modifiable, others less so.
This has made me reflect on how clearly we differentiate these patterns in clinical thinking, and whether earlier recognition might influence decision-making.
I’ve started to look at such cases less as isolated outcomes, and more as reproducible patterns that may carry their own signals.
Still early in this thinking, but it feels like an important shift.
— Ting
‘学海无涯’
Learning never stops.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment